<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="229">
<accession>P11387</accession>
<accession>A8KA78</accession>
<accession>E1P5W3</accession>
<accession>O43256</accession>
<accession>Q12855</accession>
<accession>Q12856</accession>
<accession>Q15610</accession>
<accession>Q5TFY3</accession>
<accession>Q9UJN0</accession>
<name>TOP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>DNA topoisomerase 1</fullName>
<ecNumber evidence="21 29 32 40">5.6.2.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DNA topoisomerase I</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">TOP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Proc. Natl. Acad. Sci. U.S.A." volume="85" first="2543" last="2547">
<title>cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.</title>
<authorList>
<person name="D'Arpa P."/>
<person name="Machlin P.S."/>
<person name="Ratrie H. III"/>
<person name="Rothfield N.F."/>
<person name="Cleveland D.W."/>
<person name="Earnshaw W.C."/>
</authorList>
<dbReference type="PubMed" id="2833744"/>
<dbReference type="DOI" id="10.1073/pnas.85.8.2543"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="9610" last="9616">
<title>Structure of the human type I DNA topoisomerase gene.</title>
<authorList>
<person name="Kunze N."/>
<person name="Yang G."/>
<person name="Dolberg M."/>
<person name="Sundarp R."/>
<person name="Knippers R."/>
<person name="Richter A."/>
</authorList>
<dbReference type="PubMed" id="1851751"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="194" first="323" last="330">
<title>Structural characterisation of the human DNA topoisomerase I gene promoter.</title>
<authorList>
<person name="Kunze N."/>
<person name="Klein M."/>
<person name="Richter A."/>
<person name="Knippers R."/>
</authorList>
<dbReference type="PubMed" id="2176592"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15620.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14</scope>
</reference>
<reference key="7">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-17; 107-117; 224-239; 253-262; 292-299; 355-362; 426-434; 476-484; 509-532; 550-587; 591-615; 625-634; 656-663; 694-712; 721-734 AND 736-742</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1339" last="1346">
<title>Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin.</title>
<authorList>
<person name="Fujimori A."/>
<person name="Harker W.G."/>
<person name="Kohlhagen G."/>
<person name="Hoki Y."/>
<person name="Pommier Y."/>
</authorList>
<dbReference type="PubMed" id="7882333"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 5-765</scope>
<scope>VARIANTS CPT-RESISTANT LEUKEMIA THR-370 AND SER-722</scope>
<source>
<tissue>Peripheral blood</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1988" name="Eur. J. Biochem." volume="177" first="523" last="529">
<title>Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activity.</title>
<authorList>
<person name="Oddou P."/>
<person name="Schmidt U."/>
<person name="Knippers R."/>
<person name="Richter A."/>
</authorList>
<dbReference type="PubMed" id="2461859"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1988.tb14404.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 344-765</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1989" name="Cancer Res." volume="49" first="3922" last="3927">
<title>Characterization of the 3' region of the human DNA topoisomerase I gene.</title>
<authorList>
<person name="Zhou B.S."/>
<person name="Bastow K.F."/>
<person name="Cheng Y.C."/>
</authorList>
<dbReference type="PubMed" id="2544263"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 541-765</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="8492" last="8496">
<title>Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis.</title>
<authorList>
<person name="Maul G.G."/>
<person name="Jimenez S.A."/>
<person name="Riggs E."/>
<person name="Ziemnicka-Kotula D."/>
</authorList>
<dbReference type="PubMed" id="2479024"/>
<dbReference type="DOI" id="10.1073/pnas.86.21.8492"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 657-765</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="Blood" volume="94" first="3258" last="3261">
<title>The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion.</title>
<authorList>
<person name="Ahuja H.G."/>
<person name="Felix C.A."/>
<person name="Aplan P.D."/>
</authorList>
<dbReference type="PubMed" id="10556215"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH NUP98</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="40020" last="40026">
<title>Sumoylation of topoisomerase I is involved in its partitioning between nucleoli and nucleoplasm and its clearing from nucleoli in response to camptothecin.</title>
<authorList>
<person name="Rallabhandi P."/>
<person name="Hashimoto K."/>
<person name="Mo Y.-Y."/>
<person name="Beck W.T."/>
<person name="Moitra P.K."/>
<person name="D'Arpa P."/>
</authorList>
<dbReference type="PubMed" id="12149243"/>
<dbReference type="DOI" id="10.1074/jbc.m200388200"/>
</citation>
<scope>SUMOYLATION AT LYS-117</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-103; LYS-117; LYS-153 AND TYR-723</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Virol." volume="82" first="1136" last="1145">
<title>Simian virus 40 DNA replication is dependent on an interaction between topoisomerase I and the C-terminal end of T antigen.</title>
<authorList>
<person name="Khopde S."/>
<person name="Simmons D.T."/>
</authorList>
<dbReference type="PubMed" id="18003733"/>
<dbReference type="DOI" id="10.1128/jvi.01314-07"/>
</citation>
<scope>INTERACTION WITH SV40 LARGE T ANTIGEN (MICROBIAL INFECTION)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Circ. Res." volume="104" first="589" last="599">
<title>Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.</title>
<authorList>
<person name="Eisenreich A."/>
<person name="Bogdanov V.Y."/>
<person name="Zakrzewicz A."/>
<person name="Pries A."/>
<person name="Antoniak S."/>
<person name="Poller W."/>
<person name="Schultheiss H.P."/>
<person name="Rauch U."/>
</authorList>
<dbReference type="PubMed" id="19168442"/>
<dbReference type="DOI" id="10.1161/circresaha.108.183905"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-280</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-57 AND SER-112</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="9482" last="9492">
<title>Rhythmic binding of Topoisomerase I impacts on the transcription of Bmal1 and circadian period.</title>
<authorList>
<person name="Onishi Y."/>
<person name="Kawano Y."/>
</authorList>
<dbReference type="PubMed" id="22904072"/>
<dbReference type="DOI" id="10.1093/nar/gks779"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E50427" last="E50427">
<title>CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA Binding, and increases cellular camptothecin sensitivity.</title>
<authorList>
<person name="Bandyopadhyay K."/>
<person name="Li P."/>
<person name="Gjerset R.A."/>
</authorList>
<dbReference type="PubMed" id="23185622"/>
<dbReference type="DOI" id="10.1371/journal.pone.0050427"/>
</citation>
<scope>PHOSPHORYLATION AT SER-506</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-10</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-134; LYS-153; LYS-158 AND LYS-164</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-117; LYS-148; LYS-153 AND LYS-164</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-148; LYS-153; LYS-164 AND LYS-336</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0128558" last="E0128558">
<title>Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.</title>
<authorList>
<person name="Nicolai S."/>
<person name="Filippi S."/>
<person name="Caputo M."/>
<person name="Cipak L."/>
<person name="Gregan J."/>
<person name="Ammerer G."/>
<person name="Frontini M."/>
<person name="Willems D."/>
<person name="Prantera G."/>
<person name="Balajee A.S."/>
<person name="Proietti-De-Santis L."/>
</authorList>
<dbReference type="PubMed" id="26030138"/>
<dbReference type="DOI" id="10.1371/journal.pone.0128558"/>
</citation>
<scope>INTERACTION WITH ERCC6</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-101; LYS-103; LYS-117; LYS-134; LYS-148; LYS-153; LYS-158; LYS-164; LYS-172; LYS-204; LYS-336; LYS-549; LYS-642; LYS-700 AND LYS-712</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1998" name="Science" volume="279" first="1504" last="1513">
<title>Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA.</title>
<authorList>
<person name="Redinbo M.R."/>
<person name="Stewart L."/>
<person name="Kuhn P."/>
<person name="Champoux J.J."/>
<person name="Hol W.G.J."/>
</authorList>
<dbReference type="PubMed" id="9488644"/>
<dbReference type="DOI" id="10.1126/science.279.5356.1504"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 175-765 IN COMPLEX WITH DNA</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Science" volume="279" first="1534" last="1541">
<title>A model for the mechanism of human topoisomerase I.</title>
<authorList>
<person name="Stewart L."/>
<person name="Redinbo M.R."/>
<person name="Qiu X."/>
<person name="Hol W.G.J."/>
<person name="Champoux J.J."/>
</authorList>
<dbReference type="PubMed" id="9488652"/>
<dbReference type="DOI" id="10.1126/science.279.5356.1534"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 215-765 OF MUTANT PHE-723 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2000" name="Biochemistry" volume="39" first="6832" last="6840">
<title>Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA.</title>
<authorList>
<person name="Redinbo M.R."/>
<person name="Champoux J.J."/>
<person name="Hol W.G.J."/>
</authorList>
<dbReference type="PubMed" id="10841763"/>
<dbReference type="DOI" id="10.1021/bi992690t"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 203-765 IN COMPLEX WITH DNA</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="12102" last="12107">
<title>8-Oxoguanine rearranges the active site of human topoisomerase I.</title>
<authorList>
<person name="Lesher D.T."/>
<person name="Pommier Y."/>
<person name="Stewart L."/>
<person name="Redinbo M.R."/>
</authorList>
<dbReference type="PubMed" id="12209008"/>
<dbReference type="DOI" id="10.1073/pnas.192282699"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.14 ANGSTROMS) OF 202-765 IN COMPLEX WITH DNA</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="15387" last="15392">
<title>The mechanism of topoisomerase I poisoning by a camptothecin analog.</title>
<authorList>
<person name="Staker B.L."/>
<person name="Hjerrild K."/>
<person name="Feese M.D."/>
<person name="Behnke C.A."/>
<person name="Burgin A.B. Jr."/>
<person name="Stewart L."/>
</authorList>
<dbReference type="PubMed" id="12426403"/>
<dbReference type="DOI" id="10.1073/pnas.242259599"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 174-765 IN COMPLEXES WITH DNA AND TOPOTECAN</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="12461" last="12466">
<title>Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex.</title>
<authorList>
<person name="Chrencik J.E."/>
<person name="Burgin A.B."/>
<person name="Pommier Y."/>
<person name="Stewart L."/>
<person name="Redinbo M.R."/>
</authorList>
<dbReference type="PubMed" id="12533542"/>
<dbReference type="DOI" id="10.1074/jbc.m212930200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 203-764 IN COMPLEX WITH DNA</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="2984" last="2992">
<title>The role of lysine 532 in the catalytic mechanism of human topoisomerase I.</title>
<authorList>
<person name="Interthal H."/>
<person name="Quigley P.M."/>
<person name="Hol W.G."/>
<person name="Champoux J.J."/>
</authorList>
<dbReference type="PubMed" id="14594810"/>
<dbReference type="DOI" id="10.1074/jbc.m309959200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.13 ANGSTROMS) OF 174-765</scope>
<scope>MUTAGENESIS OF LYS-532</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="339" first="773" last="784">
<title>Mechanisms of camptothecin resistance by human topoisomerase I mutations.</title>
<authorList>
<person name="Chrencik J.E."/>
<person name="Staker B.L."/>
<person name="Burgin A.B."/>
<person name="Pourquier P."/>
<person name="Pommier Y."/>
<person name="Stewart L."/>
<person name="Redinbo M.R."/>
</authorList>
<dbReference type="PubMed" id="15165849"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.03.077"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 201-765 IN COMPLEX WITH DNA AND TOPOTECAN</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2005" name="J. Med. Chem." volume="48" first="2336" last="2345">
<title>Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.</title>
<authorList>
<person name="Staker B.L."/>
<person name="Feese M.D."/>
<person name="Cushman M."/>
<person name="Pommier Y."/>
<person name="Zembower D."/>
<person name="Stewart L."/>
<person name="Burgin A.B."/>
</authorList>
<dbReference type="PubMed" id="15801827"/>
<dbReference type="DOI" id="10.1021/jm049146p"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 174-765 IN COMPLEXES WITH DNA AND SYNTHETIC INHIBITORS</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2005" name="J. Med. Chem." volume="48" first="4803" last="4814">
<title>Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.</title>
<authorList>
<person name="Ioanoviciu A."/>
<person name="Antony S."/>
<person name="Pommier Y."/>
<person name="Staker B.L."/>
<person name="Stewart L."/>
<person name="Cushman M."/>
</authorList>
<dbReference type="PubMed" id="16033260"/>
<dbReference type="DOI" id="10.1021/jm050076b"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 174-765 IN COMPLEX WITH DNA AND SYNTHETIC INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1991" name="Nucleic Acids Res." volume="19" first="69" last="75">
<title>Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.</title>
<authorList>
<person name="Tamura H."/>
<person name="Kohchi C."/>
<person name="Yamada R."/>
<person name="Ikeda T."/>
<person name="Koiwai O."/>
<person name="Patterson E."/>
<person name="Keene J.D."/>
<person name="Okada K."/>
<person name="Kjeldsen E."/>
<person name="Nishikawa K."/>
</authorList>
<dbReference type="PubMed" id="1849260"/>
<dbReference type="DOI" id="10.1093/nar/19.1.69"/>
</citation>
<scope>VARIANT CPT-RESISTANT LEUKEMIA GLY-533</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1992" name="Biochem. Biophys. Res. Commun." volume="188" first="571" last="577">
<title>Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line.</title>
<authorList>
<person name="Kubota N."/>
<person name="Kanzawa F."/>
<person name="Nishio K."/>
<person name="Takeda Y."/>
<person name="Ohmori T."/>
<person name="Fujiwara Y."/>
<person name="Terashima Y."/>
<person name="Saijo N."/>
</authorList>
<dbReference type="PubMed" id="1332703"/>
<dbReference type="DOI" id="10.1016/0006-291x(92)91094-7"/>
</citation>
<scope>VARIANT CPT-RESISTANT LUNG CANCER ALA-729</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] BREAST CANCER ARG-326</scope>
</reference>
<comment type="function">
<text evidence="20 29 32 36 37 40">Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Involved in the circadian transcription of the core circadian clock component ARNTL/BMAL1 by altering the chromatin structure around the ROR response elements (ROREs) on the ARNTL/BMAL1 promoter.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="21 29 32 40">
<text>ATP-independent breakage of single-stranded DNA, followed by passage and rejoining.</text>
<dbReference type="EC" id="5.6.2.1"/>
</reaction>
</comment>
<comment type="activity regulation">
<text>Specifically inhibited by camptothecin (CPT), a plant alkaloid with antitumor activity.</text>
</comment>
<comment type="subunit">
<text evidence="23 25 27 30 32 39 42 43">Monomer. Interacts with ERCC6 (PubMed:26030138).</text>
</comment>
<comment type="subunit">
<text evidence="34">(Microbial infection) Interacts with SV40 Large T antigen; this interactions allows viral DNA replication.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-876302">
<id>P11387</id>
</interactant>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-876302">
<id>P11387</id>
</interactant>
<interactant intactId="EBI-447544">
<id>P01106</id>
<label>MYC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-876302">
<id>P11387</id>
</interactant>
<interactant intactId="EBI-1385894">
<id>Q99801</id>
<label>NKX3-1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24">Nucleus</location>
<location evidence="24">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Nucleus</location>
<location evidence="24">Nucleoplasm</location>
</subcellularLocation>
<text>Diffuse nuclear localization with some enrichment in nucleoli. On CPT treatment, cleared from nucleoli into nucleoplasm. Sumoylated forms found in both nucleoplasm and nucleoli.</text>
</comment>
<comment type="tissue specificity">
<text evidence="36">Endothelial cells.</text>
</comment>
<comment type="PTM">
<text evidence="24">Sumoylated. Lys-117 is the main site of sumoylation. Sumoylation plays a role in partitioning TOP1 between nucleoli and nucleoplasm. Levels are dramatically increased on camptothecin (CPT) treatment.</text>
</comment>
<comment type="PTM">
<text evidence="38">Phosphorylation at Ser-506 by CK2 increases binding to supercoiled DNA and sensitivity to camptothecin.</text>
</comment>
<comment type="disease">
<text evidence="22">A chromosomal aberration involving TOP1 is found in a form of therapy-related myelodysplastic syndrome. Translocation t(11;20)(p15;q11) with NUP98.</text>
</comment>
<comment type="miscellaneous">
<text>Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.</text>
</comment>
<comment type="similarity">
<text evidence="45">Belongs to the type IB topoisomerase family.</text>
</comment>
<comment type="sequence caution" evidence="45">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="CAA36834" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TOP1ID320ch20q11.html"/>
</comment>
<dbReference type="EC" id="5.6.2.1" evidence="21 29 32 40"/>
<dbReference type="EMBL" id="J03250">
<property type="protein sequence ID" value="AAA61207.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M60706">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60688">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60689">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60690">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60691">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60692">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60693">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60694">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60695">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60696">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60697">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60698">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60699">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60700">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60701">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60702">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60703">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60704">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M60705">
<property type="protein sequence ID" value="AAA61206.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292943">
<property type="protein sequence ID" value="BAF85632.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035652">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL022394">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75994.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75995.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52601">
<property type="protein sequence ID" value="CAA36834.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U07804">
<property type="protein sequence ID" value="AAB60379.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U07806">
<property type="protein sequence ID" value="AAB60380.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16479">
<property type="protein sequence ID" value="CAA34500.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M27913">
<property type="protein sequence ID" value="AAA61208.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13312.1"/>
<dbReference type="PIR" id="A30887">
<property type="entry name" value="ISHUT1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003277.1">
<property type="nucleotide sequence ID" value="NM_003286.3"/>
</dbReference>
<dbReference type="PDB" id="1A31">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=175-765"/>
</dbReference>
<dbReference type="PDB" id="1A35">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=175-765"/>
</dbReference>
<dbReference type="PDB" id="1A36">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=175-765"/>
</dbReference>
<dbReference type="PDB" id="1EJ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=203-765"/>
</dbReference>
<dbReference type="PDB" id="1K4S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1K4T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1LPQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.14"/>
<property type="chains" value="A=202-765"/>
</dbReference>
<dbReference type="PDB" id="1NH3">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=203-765"/>
</dbReference>
<dbReference type="PDB" id="1R49">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.13"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1RR8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C=203-765"/>
</dbReference>
<dbReference type="PDB" id="1RRJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=201-765"/>
</dbReference>
<dbReference type="PDB" id="1SC7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1SEU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1T8I">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDB" id="1TL8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=174-765"/>
</dbReference>
<dbReference type="PDBsum" id="1A31"/>
<dbReference type="PDBsum" id="1A35"/>
<dbReference type="PDBsum" id="1A36"/>
<dbReference type="PDBsum" id="1EJ9"/>
<dbReference type="PDBsum" id="1K4S"/>
<dbReference type="PDBsum" id="1K4T"/>
<dbReference type="PDBsum" id="1LPQ"/>
<dbReference type="PDBsum" id="1NH3"/>
<dbReference type="PDBsum" id="1R49"/>
<dbReference type="PDBsum" id="1RR8"/>
<dbReference type="PDBsum" id="1RRJ"/>
<dbReference type="PDBsum" id="1SC7"/>
<dbReference type="PDBsum" id="1SEU"/>
<dbReference type="PDBsum" id="1T8I"/>
<dbReference type="PDBsum" id="1TL8"/>
<dbReference type="SMR" id="P11387"/>
<dbReference type="BioGRID" id="113003">
<property type="interactions" value="227"/>
</dbReference>
<dbReference type="CORUM" id="P11387"/>
<dbReference type="DIP" id="DIP-36356N"/>
<dbReference type="ELM" id="P11387"/>
<dbReference type="IntAct" id="P11387">
<property type="interactions" value="101"/>
</dbReference>
<dbReference type="MINT" id="P11387"/>
<dbReference type="STRING" id="9606.ENSP00000354522"/>
<dbReference type="BindingDB" id="P11387"/>
<dbReference type="ChEMBL" id="CHEMBL1781"/>
<dbReference type="DrugBank" id="DB07354">
<property type="generic name" value="2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM"/>
</dbReference>
<dbReference type="DrugBank" id="DB08159">
<property type="generic name" value="4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE"/>
</dbReference>
<dbReference type="DrugBank" id="DB05482">
<property type="generic name" value="7-ethyl-10-hydroxycamptothecin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04690">
<property type="generic name" value="Camptothecin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05806">
<property type="generic name" value="Cositecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB04882">
<property type="generic name" value="Edotecarin"/>
</dbReference>
<dbReference type="DrugBank" id="DB05129">
<property type="generic name" value="Elsamitrucin"/>
</dbReference>
<dbReference type="DrugBank" id="DB11254">
<property type="generic name" value="Hexylresorcinol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00762">
<property type="generic name" value="Irinotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB04967">
<property type="generic name" value="Lucanthone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06159">
<property type="generic name" value="Rubitecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB05630">
<property type="generic name" value="Sodium stibogluconate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01030">
<property type="generic name" value="Topotecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB14962">
<property type="generic name" value="Trastuzumab deruxtecan"/>
</dbReference>
<dbReference type="DrugBank" id="DB06069">
<property type="generic name" value="XMT-1001"/>
</dbReference>
<dbReference type="DrugCentral" id="P11387"/>
<dbReference type="iPTMnet" id="P11387"/>
<dbReference type="MetOSite" id="P11387"/>
<dbReference type="PhosphoSitePlus" id="P11387"/>
<dbReference type="SwissPalm" id="P11387"/>
<dbReference type="BioMuta" id="TOP1"/>
<dbReference type="DMDM" id="12644118"/>
<dbReference type="SWISS-2DPAGE" id="P11387"/>
<dbReference type="EPD" id="P11387"/>
<dbReference type="jPOST" id="P11387"/>
<dbReference type="MassIVE" id="P11387"/>
<dbReference type="MaxQB" id="P11387"/>
<dbReference type="PaxDb" id="P11387"/>
<dbReference type="PeptideAtlas" id="P11387"/>
<dbReference type="PRIDE" id="P11387"/>
<dbReference type="ProteomicsDB" id="52766"/>
<dbReference type="Antibodypedia" id="3962">
<property type="antibodies" value="415 antibodies"/>
</dbReference>
<dbReference type="CPTC" id="P11387">
<property type="antibodies" value="3 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000361337">
<property type="protein sequence ID" value="ENSP00000354522"/>
<property type="gene ID" value="ENSG00000198900"/>
</dbReference>
<dbReference type="GeneID" id="7150"/>
<dbReference type="KEGG" id="hsa:7150"/>
<dbReference type="UCSC" id="uc002xjl.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7150"/>
<dbReference type="DisGeNET" id="7150"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000198900.5"/>
<dbReference type="GeneCards" id="TOP1"/>
<dbReference type="HGNC" id="HGNC:11986">
<property type="gene designation" value="TOP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000198900">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="126420">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P11387"/>
<dbReference type="OpenTargets" id="ENSG00000198900"/>
<dbReference type="PharmGKB" id="PA353"/>
<dbReference type="eggNOG" id="KOG0981">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155006"/>
<dbReference type="HOGENOM" id="CLU_009193_0_1_1"/>
<dbReference type="InParanoid" id="P11387"/>
<dbReference type="KO" id="K03163"/>
<dbReference type="OMA" id="CSLKYEH"/>
<dbReference type="OrthoDB" id="303947at2759"/>
<dbReference type="PhylomeDB" id="P11387"/>
<dbReference type="TreeFam" id="TF105281"/>
<dbReference type="BRENDA" id="5.99.1.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P11387"/>
<dbReference type="Reactome" id="R-HSA-4615885">
<property type="pathway name" value="SUMOylation of DNA replication proteins"/>
</dbReference>
<dbReference type="SIGNOR" id="P11387"/>
<dbReference type="BioGRID-ORCS" id="7150">
<property type="hits" value="643 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="TOP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P11387"/>
<dbReference type="GeneWiki" id="TOP1"/>
<dbReference type="GenomeRNAi" id="7150"/>
<dbReference type="Pharos" id="P11387">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P11387"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="RNAct" id="P11387">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000198900">
<property type="expression patterns" value="Expressed in trabecular bone tissue and 241 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P11387">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0001650">
<property type="term" value="C:fibrillar center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000932">
<property type="term" value="C:P-body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043204">
<property type="term" value="C:perikaryon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0031298">
<property type="term" value="C:replication fork protection complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003917">
<property type="term" value="F:DNA topoisomerase type I (single strand cut, ATP-independent) activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003697">
<property type="term" value="F:single-stranded DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0097100">
<property type="term" value="F:supercoiled DNA binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006260">
<property type="term" value="P:DNA replication"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006265">
<property type="term" value="P:DNA topological change"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040016">
<property type="term" value="P:embryonic cleavage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0012501">
<property type="term" value="P:programmed cell death"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00659">
<property type="entry name" value="Topo_IB_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00075"/>
<dbReference type="Gene3D" id="1.10.10.41">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.132.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.170.11.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.15.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011010">
<property type="entry name" value="DNA_brk_join_enz"/>
</dbReference>
<dbReference type="InterPro" id="IPR013034">
<property type="entry name" value="DNA_topo_DNA_db_N_dom1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013030">
<property type="entry name" value="DNA_topo_DNA_db_N_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001631">
<property type="entry name" value="TopoI"/>
</dbReference>
<dbReference type="InterPro" id="IPR018521">
<property type="entry name" value="TopoI_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR025834">
<property type="entry name" value="TopoI_C_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR014711">
<property type="entry name" value="TopoI_cat_a-hlx-sub_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR014727">
<property type="entry name" value="TopoI_cat_a/b-sub_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR013500">
<property type="entry name" value="TopoI_cat_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR008336">
<property type="entry name" value="TopoI_DNA-bd_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR036202">
<property type="entry name" value="TopoI_DNA-bd_euk_N_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013499">
<property type="entry name" value="TopoI_euk"/>
</dbReference>
<dbReference type="Pfam" id="PF14370">
<property type="entry name" value="Topo_C_assoc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01028">
<property type="entry name" value="Topoisom_I"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02919">
<property type="entry name" value="Topoisom_I_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00416">
<property type="entry name" value="EUTPISMRASEI"/>
</dbReference>
<dbReference type="SMART" id="SM00435">
<property type="entry name" value="TOPEUc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56349">
<property type="entry name" value="SSF56349"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56741">
<property type="entry name" value="SSF56741"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00176">
<property type="entry name" value="TOPOISOMERASE_I_EUK"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0413">Isomerase</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0799">Topoisomerase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="11 12 44">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="DNA topoisomerase 1" id="PRO_0000145201">
<location>
<begin position="2"/>
<end position="765"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="425"/>
<end position="426"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="488"/>
<end position="493"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DNA">
<location>
<begin position="585"/>
<end position="587"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich">
<location>
<begin position="23"/>
<end position="204"/>
</location>
</feature>
<feature type="active site" description="O-(3'-phospho-DNA)-tyrosine intermediate" evidence="21 23 26 27 30 31 32 42">
<location>
<position position="723"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="316"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="364"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="412"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="443"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="501"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="532"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="574"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="632"/>
</location>
</feature>
<feature type="site" description="Interaction with DNA">
<location>
<position position="650"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="11 12 44">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="57"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="112"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="19">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="10">
<location>
<position position="280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="38">
<location>
<position position="506"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="101"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="45">
<location>
<position position="103"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="18">
<location>
<position position="103"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="117"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="14">
<location>
<position position="117"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="14 15 17 18">
<location>
<position position="117"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 18">
<location>
<position position="134"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18">
<location>
<position position="148"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="45">
<location>
<position position="153"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="15 16 17 18">
<location>
<position position="153"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 18">
<location>
<position position="158"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15 16 17 18">
<location>
<position position="164"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="18">
<location>
<position position="172"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="204"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 18">
<location>
<position position="336"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="549"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="642"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="700"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6029542." id="VAR_052592">
<original>G</original>
<variation>S</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer; somatic mutation." id="VAR_036555" evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="326"/>
</location>
</feature>
<feature type="sequence variant" description="In CPT-resistant leukemia." id="VAR_010666" evidence="41">
<original>M</original>
<variation>T</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In CPT-resistant leukemia; dbSNP:rs267607131." id="VAR_007530" evidence="35">
<original>D</original>
<variation>G</variation>
<location>
<position position="533"/>
</location>
</feature>
<feature type="sequence variant" description="In CPT-resistant leukemia." id="VAR_010667" evidence="41">
<original>N</original>
<variation>S</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence variant" description="In CPT-resistant lung cancer." id="VAR_007531" evidence="28">
<original>T</original>
<variation>A</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="mutagenesis site" description="Localizes in both nucleoplasm and nucleoli; when associated with R-117 or R-153. Almost complete loss of sumoylation, concentrates in nucleoli and no clearing from nucleoli on CPT treatment; when associated with R-117 and R-153." evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="5-fold decrease in sumoylation. Localizes in both nucleoplasm and nucleoli; when associated with or without R-103 or R-153. Almost complete loss of sumoylation, concentrates in nucleoli and no clearing from nucleoli on CPT treatment; when associated with R-103 and R-153." evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="Localizes in both nucleoplasm and nucleoli; when associated with R-103 or R-117. Almost complete loss of sumoylation, concentrates in nucleoli and no clearing from nucleoli on CPT treatment; when associated with R-103 and R-117." evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost abolishes enzyme activity." evidence="29">
<original>K</original>
<variation>A</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced enzyme activity." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="532"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in CPT-induced clearing from nuclei." evidence="24">
<original>Y</original>
<variation>F</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA61207." ref="1" evidence="45">
<original>A</original>
<variation>V</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="205"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="220"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="240"/>
<end position="242"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="251"/>
<end position="261"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="262"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="272"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="288"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="297"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="303"/>
<end position="317"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="321"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="339"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="346"/>
<end position="351"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="368"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="379"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="383"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="396"/>
<end position="398"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="413"/>
<end position="417"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="424"/>
<end position="427"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="431"/>
<end position="433"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="434"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="485"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="495"/>
<end position="497"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="504"/>
<end position="506"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="509"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="514"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="521"/>
<end position="530"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="532"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="536"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="545"/>
<end position="553"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="564"/>
<end position="567"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="570"/>
<end position="580"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="581"/>
<end position="583"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="586"/>
<end position="605"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="608"/>
<end position="610"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="612"/>
<end position="625"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="626"/>
<end position="631"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="640"/>
<end position="643"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="644"/>
<end position="673"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="678"/>
<end position="710"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="712"/>
<end position="714"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="721"/>
<end position="723"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="726"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="740"/>
<end position="742"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="746"/>
<end position="751"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="753"/>
<end position="758"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A31"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A35"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A36"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K4S"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K4T"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1NH3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SC7"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SEU"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T8I"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q04750"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q13472"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10130"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10556215"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10841763"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12149243"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12209008"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12426403"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12533542"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1332703"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14594810"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15165849"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15801827"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16033260"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18003733"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1849260"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19168442"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22904072"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23185622"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26030138"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2833744"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7882333"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9488644"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9488652"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<sequence length="765" mass="90726" checksum="6FBED540BCF7BE28" modified="2000-12-01" version="2">MSGDHLHNDSQIEADFRLNDSHKHKDKHKDREHRHKEHKKEKDREKSKHSNSEHKDSEKKHKEKEKTKHKDGSSEKHKDKHKDRDKEKRKEEKVRASGDAKIKKEKENGFSSPPQIKDEPEDDGYFVPPKEDIKPLKRPRDEDDADYKPKKIKTEDTKKEKKRKLEEEEDGKLKKPKNKDKDKKVPEPDNKKKKPKKEEEQKWKWWEEERYPEGIKWKFLEHKGPVFAPPYEPLPENVKFYYDGKVMKLSPKAEEVATFFAKMLDHEYTTKEIFRKNFFKDWRKEMTNEEKNIITNLSKCDFTQMSQYFKAQTEARKQMSKEEKLKIKEENEKLLKEYGFCIMDNHKERIANFKIEPPGLFRGRGNHPKMGMLKRRIMPEDIIINCSKDAKVPSPPPGHKWKEVRHDNKVTWLVSWTENIQGSIKYIMLNPSSRIKGEKDWQKYETARRLKKCVDKIRNQYREDWKSKEMKVRQRAVALYFIDKLALRAGNEKEEGETADTVGCCSLRVEHINLHPELDGQEYVVEFDFLGKDSIRYYNKVPVEKRVFKNLQLFMENKQPEDDLFDRLNTGILNKHLQDLMEGLTAKVFRTYNASITLQQQLKELTAPDENIPAKILSYNRANRAVAILCNHQRAPPKTFEKSMMNLQTKIDAKKEQLADARRDLKSAKADAKVMKDAKTKKVVESKKKAVQRLEEQLMKLEVQATDREENKQIALGTSKLNYLDPRITVAWCKKWGVPIEKIYNKTQREKFAWAIDMADEDYEF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

